<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-11T13:38:06+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-CIV-C-ACI-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Intensification and improvement of quality HIV interventions to reach the 95-95-95 target and scaling up of TB interventions to combat tuberculosis in Côte d’Ivoire - Côte d'Ivoire (01-Jan-2021-31-Dec-2023)</narrative>
    </title>
    <description type="1">
      <narrative>Côte d'Ivoire, TB/HIV, Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Réduire le nombre de décès lié à la tuberculose de 60 % à l’horizon 2025 par rapport à l’année 2015  / Reduce the number of deaths from tuberculosis by 60% by 2025 compared to the year 2015; Réduire l’incidence de la tuberculose de 50% à l’horizon 2025 par rapport à l’année 2015  /  Reduce the incidence of tuberculosis by 50% by the year 2025 compared to the year 2015; En 2025, les nouvelles infections à VIH sont réduites de 70% (en prenant compte année de base 2020) / In 2025, new HIV infections are reduced by 70% (taking into account baseline year 2020); En 2025, la mortalité liée au VIH est réduite de 50% (en prenant compte année de base 2020) / In 2025, HIV-related mortality is reduced by 50% (taking into account baseline year 2020). Objectives: Accroître la notification des nouveaux cas et rechutes de tuberculose toutes formes de 21 034 en 2018 à 25 754 en 2023  /  Increase the notification of new cases and relapses of all forms of tuberculosis from 21,034 in 2018 to 25,754 in 2023; Atteindre 90% de taux de succès thérapeutique chez les nouveaux cas et rechutes de tuberculose toutes formes d’ici 2023  /  Achieve 90% treatment success rate in new and relapsed cases of all forms of tuberculosis by 2023; Atteindre 84% de taux de succès thérapeutique chez les malades multi-résistants mis sous traitement de 2ème ligne d’ici 2023  /  Achieve 84% treatment success rate in multi-drug resistant patients put on 2nd line therapy by 2023; Intensifier et améliorer la qualité des interventions en vue de l'atteinte des 95-95-95 d'ici 2025 / Accelerate and improve the quality of interventions to achieve the 95-95-95 by 2025; La réduction de la stigmatisation et de la discrimination et le respect des droits humains renforcent l'ensemble des interventions de prévention et de prise en charge du VIH/sida / Reduced stigma and discrimination, and respect for human rights reinforce all HIV / AIDS prevention and care interventions; Renforcer les capacités de gestion et de coordination du programme à tous les niveaux  /  Strengthen programme management and coordination capacities at all levels; La gouvernance de la réponse au VIH/sida et aux IST est renforcée à tous les niveaux pour en assurer l’accélération, l'efficience, la redevabilité et la durabilité / The governance of the HIV / AIDS response and STIs is strengthened at all levels to ensure acceleration, efficiency, accountability and sustainability. Il s'agira spécifiquement de Renforcer les parties prenantes à la fois sur la participation et la redevabilité citoyenne dans les systèmes de prestations de services.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
    </participating-org>
    <other-identifier ref="CIV-C-ACIP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2021-01-01" />
    <activity-date type="2" iso-date="2021-01-01" />
    <activity-date type="3" iso-date="2023-12-31" />
    <activity-date type="4" iso-date="2023-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Paula Hacopian</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>paula.hacopian@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="CI" percentage="100">
      <narrative>Côte d'Ivoire</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="45.11">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="44.1">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="10.79">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="2f83940f-3956-46e3-aeb4-0a2b2ee56af3" percentage="1.84">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="f83bbdd0-a94f-473b-9cc3-ae8a59141348" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing</narrative>
        </description>
      </budget-item>
      <budget-item code="67b7abf2-42e5-4cc4-b75d-4eb6ea4f22b4" percentage="0.55">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
        </description>
      </budget-item>
      <budget-item code="1e10e245-2f3d-48cc-8d98-b02bf369e956" percentage="0.99">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 1: Primary prevention of HIV infection among women of childbearing age</narrative>
        </description>
      </budget-item>
      <budget-item code="8cc23209-2129-4c18-b058-a4c3a63b6ae4" percentage="1.54">
        <description>
          <narrative>HIV -&gt; PMTCT -&gt; Prong 3: Preventing vertical HIV transmission</narrative>
        </description>
      </budget-item>
      <budget-item code="db409d6f-4960-4f12-859f-6ad60fa29f5a" percentage="0.19">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Addressing stigma, discrimination and violence</narrative>
        </description>
      </budget-item>
      <budget-item code="88657fe2-2942-4159-860a-af9e84e64238" percentage="7.69">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Behavior change interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="4cda1636-6187-4ff6-8ed5-1fcceeb830bf" percentage="2.86">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Comprehensive sexuality education for AGYW and adolescent boys and young men (ABYM)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0f7e056-b292-405c-81ee-0e3d059dde00" percentage="0.7">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Condom and lubricant programming</narrative>
        </description>
      </budget-item>
      <budget-item code="e5a28ba0-ab59-4fc0-aba6-e677caad3c6c" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Gender-based violence prevention and post violence care</narrative>
        </description>
      </budget-item>
      <budget-item code="d114003b-2059-4703-bbdf-e540a4be0418" percentage="1.67">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Harm reduction interventions for drug use</narrative>
        </description>
      </budget-item>
      <budget-item code="a3504d0a-dbb3-4856-bf17-a66b51f66b6a" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Integration into national multi-sectoral responses of AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="dca7e9d2-7860-49a4-8fb9-9fe629cd8d8c" percentage="0.87">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Interventions for young key populations</narrative>
        </description>
      </budget-item>
      <budget-item code="9f962c9c-535f-402a-bf31-93ae95faed44" percentage="0.21">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Needle and syringe programs</narrative>
        </description>
      </budget-item>
      <budget-item code="61bfa00d-5158-4201-9e12-b91bee129c91" percentage="0.16">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Pre-exposure prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="e2860998-43fe-4145-aabf-08302069b9f1" percentage="0.23">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Sexual and reproductive health services, including STIs</narrative>
        </description>
      </budget-item>
      <budget-item code="a90c4f80-192f-4c1b-a9c0-978c47b6fe31" percentage="0.28">
        <description>
          <narrative>HIV -&gt; Prevention -&gt; Social protection interventions</narrative>
        </description>
      </budget-item>
      <budget-item code="06f7d2bb-99d8-4c7b-95d2-bc02c0b90b93" percentage="0.63">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="0597f88b-5b88-4b47-8d91-6f7889b4f36f" percentage="2.06">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
        </description>
      </budget-item>
      <budget-item code="56595a18-f1ed-4f39-8c05-d687d5911e6b" percentage="0.26">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="0d76926d-3ff4-4be9-b57c-a4cbfd9a134f" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="fe7b40b4-5c8d-41e2-b78b-e98fa68cabe7" percentage="0.54">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights" campaign)</narrative>
        </description>
      </budget-item>
      <budget-item code="3980356a-cb5d-41ef-9ac0-654bcf4991e7" percentage="3.27">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="1f63d5bb-7cf1-4ecd-a1a0-6f951b7f88a7" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
        </description>
      </budget-item>
      <budget-item code="9476a49e-917c-4607-b0d3-5ccee13653a6" percentage="2.92">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="336e2f1a-7395-4d59-b42e-5e9916975074" percentage="4.97">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="8.61">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="7512cda1-0b75-4562-9739-f7dd18a3afe6" percentage="0.2">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Orphan and vulnerable children package</narrative>
        </description>
      </budget-item>
      <budget-item code="62adfb99-3345-4b03-ad9f-89b544624a5b" percentage="1.4">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="6a7cb452-4c5d-49b6-aa43-8437d24fa1c5" percentage="2.79">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="32.61">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="a459608e-6d6a-4392-8e91-a6ce763883ca" percentage="1.31">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="25710664-d25f-448a-9b94-5e4b210a97c6" percentage="4.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.09">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="d110361a-331b-4f72-bd32-016450445cc3" percentage="2.77">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="0.19">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="b235c58e-3a80-49b8-aeb9-ddaad2b16768" percentage="0.24">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Surveys</narrative>
        </description>
      </budget-item>
      <budget-item code="30f85a5d-1110-4276-932f-a742fc65c90f" percentage="0.03">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="0.23">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="95aeb1ae-4531-4aec-8557-537759098b9c" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Legal literacy ("Know Your Rights")</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="0.3">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="5.73">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="9afa836c-5fc6-4ff5-973e-19cb5f9bc599" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="0.05">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.61">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="0ab3436b-1630-4594-a015-5ea84f3e012d" percentage="0.14">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Miners and mining communities</narrative>
        </description>
      </budget-item>
      <budget-item code="3d30473b-46e8-4203-ad93-10040d8517cb" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="87435fc1-d92b-4039-b203-96061e6e85be" percentage="0.45">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Key populations (TB care and prevention) - Prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="2.57">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0.12">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3844a48b-ee6f-484c-866d-4d19de42ce72" percentage="0.43">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="f9ff8a94-1fc1-4acf-863f-a191df107ee9" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">10229058.80</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">12811474.65</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">20298125.24</value>
    </budget>
    <capital-spend percentage="7.78" />
    <transaction ref="f3a68125-e836-41c6-86bb-5e94fc50c7e6">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-12-18" />
      <value currency="USD" value-date="2020-12-18">21822035.11</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8d53d158-a6ab-464d-997b-4e9082bfd263">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-08" />
      <value currency="USD" value-date="2021-01-08">2652643.25</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8b97b17c-7a9d-4d7f-a80b-b237451f1a94">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-10" />
      <value currency="USD" value-date="2021-06-10">4079597.25</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ac76befe-724f-4080-a6c4-d8179bc4fae4">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-10" />
      <value currency="USD" value-date="2021-06-10">213196.50</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="367c236b-6667-4d3e-befe-cd6d7aa6d478">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-29" />
      <value currency="USD" value-date="2021-07-29">2943823.04</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="030bdcf0-255b-4bd7-a1e5-a1afbf097261">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-18" />
      <value currency="USD" value-date="2021-08-18">163876.35</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e215be4d-f402-4fbb-bc5a-c43f44c6e5cd">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-08-26" />
      <value currency="USD" value-date="2021-08-26">-49320.16</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="11ccf33a-1e42-45f5-9b6e-1dee37d40557">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-16" />
      <value currency="USD" value-date="2021-09-16">49809.73</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="152ac1ce-8b9a-4cd7-881c-5e21644dab1a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-16" />
      <value currency="USD" value-date="2021-09-16">-489.57</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="57565486-6a9c-482a-9946-937ef61c4a6f">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">-49809.73</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="66a68f8b-0d95-4bd9-95ad-8de06f5c967b">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-09-18" />
      <value currency="USD" value-date="2021-09-18">52328.36</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aad57286-fbef-4bb0-a07e-e4ed6451e323">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-11-01" />
      <value currency="USD" value-date="2021-11-01">22.06</value>
      <description>
        <narrative>Funds returned to the Global Fund from CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a57b636e-8c0b-4eb1-ab5d-bde11806ce12">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">2687422.64</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bc47c03c-b23e-46da-ae37-c20b3569a357">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">2147204.13</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="83a2704e-f8d6-4caf-980b-3e9392743272">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-29" />
      <value currency="USD" value-date="2021-11-29">-22.06</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e66380b3-cbbc-4b91-94c1-eac3e17d6230">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-02-07" />
      <value currency="USD" value-date="2022-02-07">52328.36</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="38ace3b7-3213-424a-b652-b6d80bc5ebc8">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-17" />
      <value currency="USD" value-date="2022-03-17">2310976.36</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="45c1956e-3070-4d52-a256-32ff73fa686c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">101114.84</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="113746aa-f7f4-4801-86e0-10ec0ea5047d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">3345972.46</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fcc10ba2-df61-4fc2-a7ca-8f715edc7f42">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-07" />
      <value currency="USD" value-date="2022-07-07">5054.95</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0c72eb53-1fb0-4f74-98f4-48bbf6f10fe7">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-15" />
      <value currency="USD" value-date="2022-09-15">5224.78</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d9614d49-52ba-45de-92ad-d1e130cb5eaa">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-27" />
      <value currency="USD" value-date="2022-10-27">-1543001.40</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3c21ec46-2506-4a62-8ab1-03510ff8ab0e">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-10-27" />
      <value currency="USD" value-date="2022-10-27">15088968.69</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0ada8bbd-2164-4d6b-a7ff-4a8b9b9bcd6c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-11-01" />
      <value currency="USD" value-date="2022-11-01">6315252.26</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="47794962-2bf5-41f2-bc06-454dd90da8ed">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-29" />
      <value currency="USD" value-date="2023-04-29">43537.84</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="eb798c89-4d22-4995-9e24-51c68ca44d87">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">62586.44</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="24ca1aa8-96bc-4619-ae62-e6648891fe78">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-06-06" />
      <value currency="USD" value-date="2023-06-06">993235.54</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e7d2d4f0-7814-466f-b2c8-779bab92a6b6">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-20" />
      <value currency="USD" value-date="2023-07-20">36962.50</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9b66c915-28ba-4cb2-bc20-cd52be407e35">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-25" />
      <value currency="USD" value-date="2023-07-25">909232.89</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="83dd4e2c-7c2a-4abf-b654-3e5b980c9b41">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-07-25" />
      <value currency="USD" value-date="2023-07-25">3177961.73</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="795355a6-a3f7-4946-9e06-b4851000655e">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-05" />
      <value currency="USD" value-date="2023-09-05">4495636.21</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="408cc3f1-22d8-4f9f-b3aa-0eb1ca99a1d5">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-05" />
      <value currency="USD" value-date="2023-09-05">-3630699.83</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d793ddea-4e26-4509-ace9-9695f771975f">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">812776.94</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="164d0921-ed05-4938-9050-d6b29d1df5ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-09-08" />
      <value currency="USD" value-date="2023-09-08">26433.53</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7664f1ef-2577-45fd-9e12-59ddce83b415">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-20" />
      <value currency="USD" value-date="2023-09-20">-6575.34</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="20fd81ba-695d-4c76-8da0-56f9384f23cc">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-09-20" />
      <value currency="USD" value-date="2023-09-20">136070.47</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="944f8001-ca3c-47e5-80e8-021f1dcaad5a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-11" />
      <value currency="USD" value-date="2023-10-11">-136070.47</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="06371394-c2b8-4107-8501-4b325db916b5">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-10-11" />
      <value currency="USD" value-date="2023-10-11">231669.08</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ede46dac-e653-484e-a90f-b4b2d3415449">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-02" />
      <value currency="USD" value-date="2023-11-02">2939791.58</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8a260faa-e150-4bb5-9588-c8787b219224">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-02" />
      <value currency="USD" value-date="2023-11-02">326316.98</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="cc538086-fee6-4209-9f3e-57314cd91508">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-11-28" />
      <value currency="USD" value-date="2023-11-28">6398.07</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b4dabeb4-4d62-4e59-8988-c9f409e79e14">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">-225271.01</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="25887b88-7b26-47a7-abfb-1540fcbdef37">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-19" />
      <value currency="USD" value-date="2023-12-19">225271.00</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="582ef0e3-46b1-4a36-aad2-e7a427ceb05d">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-22" />
      <value currency="USD" value-date="2023-12-22">120156.32</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="1dbd7e98-8714-4c5d-bab7-42ef600d7cf1">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-09" />
      <value currency="USD" value-date="2024-01-09">67968.87</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8d7ad952-6a5e-49f2-9df5-56a1ca9f2480">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-09" />
      <value currency="USD" value-date="2024-01-09">-157302.12</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="747427be-0050-48cc-9e6d-4dd3d7373b2b">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-01-09" />
      <value currency="USD" value-date="2024-01-09">156862.70</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bdefdf06-d12e-4061-81c2-979ea9dc359b">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-06" />
      <value currency="USD" value-date="2024-02-06">14223.34</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a3dc4b96-e231-47a4-bdd4-27c2d5ed5d90">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-06" />
      <value currency="USD" value-date="2024-02-06">101876.27</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b318688b-f052-4575-8a81-de7ee5f461f3">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-02-13" />
      <value currency="USD" value-date="2024-02-13">11644.92</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9e19df0c-8eb9-4e41-bb64-d98b1837d159">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-02" />
      <value currency="USD" value-date="2024-04-02">105725.66</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="fcb3f700-c539-4092-ae88-bca7e7c4c17f">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-10" />
      <value currency="USD" value-date="2024-04-10">-390317.18</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5f166ae8-c660-49f2-9b66-2f4d24635452">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-10" />
      <value currency="USD" value-date="2024-04-10">1136587.85</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="30b7bed1-de89-446d-890d-1261d0f404ac">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-11" />
      <value currency="USD" value-date="2024-04-11">1136587.85</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="876695ea-9f6b-4345-9eb6-f97c2d4642c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-14" />
      <value currency="USD" value-date="2024-04-14">-29118.17</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="119ace4e-1023-47cd-b1c5-18a45c47335d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-14" />
      <value currency="USD" value-date="2024-04-14">28461.92</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="624d79c5-3d50-430a-9b8e-e6901b30b989">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-16" />
      <value currency="USD" value-date="2024-04-16">28461.91</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3f568a0e-0982-4303-bec0-685e11ed4a70">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-16" />
      <value currency="USD" value-date="2024-04-16">-28461.92</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4f5cbeab-e1bf-44e2-80c3-7f429ed305f5">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-18" />
      <value currency="USD" value-date="2024-04-18">24444.57</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e3f235b4-74c6-4331-9849-2c4f079efa49">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-20" />
      <value currency="USD" value-date="2024-05-20">-4017.34</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9717e90f-33a6-44ed-b325-a7f8d51f4fd5">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-20" />
      <value currency="USD" value-date="2024-05-20">4012.14</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="81a7a7d3-9d7c-4a1b-bb88-4eaca6773ea2">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-18" />
      <value currency="USD" value-date="2024-06-18">12891.27</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP01 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="1bb6a1ee-8bcd-42ec-bba4-a2fecf2abd9c">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-28" />
      <value currency="USD" value-date="2024-07-28">0.01</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="01f2a68d-c053-4dc4-8abf-b019568d2d6d">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-07-28" />
      <value currency="USD" value-date="2024-07-28">-1539.39</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7d86c2ab-ad47-4ccd-9cee-4e114ddebdae">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">-157480.84</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b5907fd3-831f-429c-897b-cf971c182abc">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">157480.84</value>
      <description>
        <narrative>Funds returned to the Global Fund from CIV-C-ACIP01 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="CIV-C-ACIP01-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">10230451.46</value>
      <description>
        <narrative>Expenditure reported by Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire for CIV-C-ACIP01, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </provider-org>
    </transaction>
    <transaction ref="CIV-C-ACIP01-EXP-20221231">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-12-31">12802211.54</value>
      <description>
        <narrative>Expenditure reported by Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire for CIV-C-ACIP01, Jan 2022 to Dec 2022.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </provider-org>
    </transaction>
    <transaction ref="CIV-C-ACIP01-EXP-20231231">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-12-31">15636299.89</value>
      <description>
        <narrative>Expenditure reported by Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire for CIV-C-ACIP01, Jan 2023 to Dec 2023.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </provider-org>
    </transaction>
    <transaction ref="CIV-C-ACIP01-EXP-20240630">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-06-30" />
      <value currency="USD" value-date="2024-06-30">788971.75</value>
      <description>
        <narrative>Expenditure reported by Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire for CIV-C-ACIP01, Jan 2024 to Jun 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/CIV-C-ACI" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/CIV/2020/Tuberculosis/en/CIV-T_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 1 - Tuberculosis - Côte d'Ivoire - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR747-CIV-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-03-23" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/CIV/2020/Tuberculosis/fr/CIV-T_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 1 - Tuberculosis - Côte d'Ivoire - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR747-CIV-T.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2020-03-23" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/CIV/2020/HIV/en/CIV-H_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2b - HIV - Côte d'Ivoire - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR941-CIV-H.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2020-05-31" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/CIV/2020/HIV/fr/CIV-H_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2020 - Funding Request - Window 2b - HIV - Côte d'Ivoire - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR941-CIV-H.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2020-05-31" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-Other 1 Percentage of MSM newly diagnosed with HIV and enrolled in an ARV treatment site during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-Other 1 Percentage of MSM newly diagnosed with HIV and enrolled in an ARV treatment site during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="100">
          <comment>
            <narrative>Numerator: 157; Denominator: 157.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 310; Denominator: 310.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 71; Denominator: 71.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 155; Denominator: 155.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 24; Denominator: 24.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 155; Denominator: 155.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 47; Denominator: 47.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 318; Denominator: 318.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 82; Denominator: 82.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 159; Denominator: 159.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 48; Denominator: 48.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 159; Denominator: 159.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 34; Denominator: 34.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 327; Denominator: 327.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 84; Denominator: 84.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 163; Denominator: 163.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 39; Denominator: 39.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 164; Denominator: 164.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 45; Denominator: 45.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-Other 2 Percentage of sex workers newly diagnosed with HIV and enrolled in an ARV treatment site during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-Other 2 Percentage of sex workers newly diagnosed with HIV and enrolled in an ARV treatment site during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="99.27">
          <comment>
            <narrative>Numerator: 409; Denominator: 412.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 296; Denominator: 296.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 96; Denominator: 96.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 592; Denominator: 592.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 354; Denominator: 354.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 296; Denominator: 296.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 258; Denominator: 258.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 304; Denominator: 304.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 156; Denominator: 156.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 608; Denominator: 608.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 269; Denominator: 269.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 304; Denominator: 304.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 113; Denominator: 113.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 624; Denominator: 624.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 281; Denominator: 281.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 312; Denominator: 312.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 109; Denominator: 109.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 312; Denominator: 312.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 172; Denominator: 172.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HTS-Other 3 Percentage of drug users (including PWID) newly diagnosed with HIV and enrolled in an ARV treatment site during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>HTS-Other 3 Percentage of drug users (including PWID) newly diagnosed with HIV and enrolled in an ARV treatment site during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="98.65">
          <comment>
            <narrative>Numerator: 73; Denominator: 74.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 107; Denominator: 107.</narrative>
            </comment>
          </target>
          <actual value="97.1">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 53; Denominator: 53.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 11; Denominator: 11.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 54; Denominator: 54.</narrative>
            </comment>
          </target>
          <actual value="95.8">
            <comment>
              <narrative>Numerator: 23; Denominator: 24.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 117; Denominator: 117.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 30; Denominator: 30.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 58; Denominator: 58.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 14; Denominator: 14.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 59; Denominator: 59.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 16; Denominator: 16.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 63; Denominator: 63.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 15; Denominator: 15.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 126; Denominator: 126.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 28; Denominator: 28.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 63; Denominator: 63.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 13; Denominator: 13.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of adolescent girls and young women who were tested for HIV and received their results during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of adolescent girls and young women who were tested for HIV and received their results during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 98895.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 98895.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 98895.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 98895.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 98895.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 98895.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-24" />
          <comment>
            <narrative>Numerator: 185616.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-24" />
          <comment>
            <narrative>Numerator: 185616.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-24" />
          <comment>
            <narrative>Numerator: 185616.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-24" />
          <comment>
            <narrative>Numerator: 185616.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-24" />
          <comment>
            <narrative>Numerator: 185616.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-24" />
          <comment>
            <narrative>Numerator: 185616.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 86721.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 86721.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 86721.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 86721.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 86721.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 86721.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 185187.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 185187.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 185187.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 185187.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 185187.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 185187.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 429.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 429.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 429.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 429.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 429.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 429.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 17154.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-24" />
            <comment>
              <narrative>Numerator: 32619.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 15465.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 32596.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 23.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 33282.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-24" />
            <comment>
              <narrative>Numerator: 61871.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 28589.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 61783.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 88.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 34461.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-24" />
            <comment>
              <narrative>Numerator: 62135.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 27674.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 62066.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 69.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 30823; Denominator: 56191; Percentage: 54.85%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-24" />
            <comment>
              <narrative>Numerator: 56191.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 25368; Denominator: 56191; Percentage: 45.15%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 56148; Denominator: 56191; Percentage: 99.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 43; Denominator: 56191; Percentage: 0.08%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 23802.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-24" />
            <comment>
              <narrative>Numerator: 43923.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 20121.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 43889; Denominator: 43923; Percentage: 99.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 34; Denominator: 43923; Percentage: 0.08%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 28024.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-24" />
            <comment>
              <narrative>Numerator: 52761.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 24737.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 52724.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 37.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 64820; Denominator: 307147.18; Percentage: 21.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 64352.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 64352.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 64352.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 64352.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 64352.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Negative" />
          <comment>
            <narrative>Numerator: 64352.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 468.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 468.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 468.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 468.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 468.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 468.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 34918.85; Denominator: 232792.3; Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 12932; Denominator: 232792; Percentage: 5.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 12851.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 85.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 69837.6; Denominator: 232792.3; Percentage: 30%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 50627; Denominator: 232792; Percentage: 21.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 34918.85; Denominator: 232792.3; Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 37695; Denominator: 232792; Percentage: 16.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 37542.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 153.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 35826.73; Denominator: 238844.84; Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 34433; Denominator: 238845; Percentage: 14.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 34314.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 119.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 71653.4; Denominator: 238844.8; Percentage: 30%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 61814; Denominator: 238845; Percentage: 25.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 35826.73; Denominator: 238844.84; Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 27381; Denominator: 238845; Percentage: 11.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 27292; Denominator: 27381; Percentage: 99.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 89; Denominator: 27381; Percentage: 0.33%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 36758.24; Denominator: 245054.94; Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 25734; Denominator: 245055; Percentage: 10.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 25643; Denominator: 25734; Percentage: 99.65%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 91; Denominator: 25734; Percentage: 0.35%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 73516.4; Denominator: 245054.9; Percentage: 30%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 61328; Denominator: 245055; Percentage: 25%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 36758.24; Denominator: 245054.94; Percentage: 15%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 35594; Denominator: 245055; Percentage: 14.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Negative" />
            <comment>
              <narrative>Numerator: 35511.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 83.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>KP-Other 1 Percentage of drug users (including PWID) who have benefited from preventive HIV programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>KP-Other 1 Percentage of drug users (including PWID) who have benefited from preventive HIV programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="56.17">
          <comment>
            <narrative>Numerator: 4587; Denominator: 8167.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="33.25">
            <comment>
              <narrative>Numerator: 3338; Denominator: 10039.</narrative>
            </comment>
          </target>
          <actual value="4.1">
            <comment>
              <narrative>Numerator: 413; Denominator: 10039.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="66.5">
            <comment>
              <narrative>Numerator: 6676; Denominator: 10039.</narrative>
            </comment>
          </target>
          <actual value="48.4">
            <comment>
              <narrative>Numerator: 4863; Denominator: 10039.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="33.25">
            <comment>
              <narrative>Numerator: 3338; Denominator: 10039.</narrative>
            </comment>
          </target>
          <actual value="44.3">
            <comment>
              <narrative>Numerator: 4450; Denominator: 10039.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="71.2">
            <comment>
              <narrative>Numerator: 7336; Denominator: 10300.</narrative>
            </comment>
          </target>
          <actual value="85">
            <comment>
              <narrative>Numerator: 8756; Denominator: 10300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="35.61">
            <comment>
              <narrative>Numerator: 3668; Denominator: 10300.</narrative>
            </comment>
          </target>
          <actual value="48.6">
            <comment>
              <narrative>Numerator: 5008; Denominator: 10300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="35.61">
            <comment>
              <narrative>Numerator: 3668; Denominator: 10300.</narrative>
            </comment>
          </target>
          <actual value="36.4">
            <comment>
              <narrative>Numerator: 3748; Denominator: 10300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="74.7">
            <comment>
              <narrative>Numerator: 7894; Denominator: 10568.</narrative>
            </comment>
          </target>
          <actual value="75.8">
            <comment>
              <narrative>Numerator: 8014; Denominator: 10568.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="37.35">
            <comment>
              <narrative>Numerator: 3947; Denominator: 10568.</narrative>
            </comment>
          </target>
          <actual value="44.8">
            <comment>
              <narrative>Numerator: 4736; Denominator: 10568.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="37.35">
            <comment>
              <narrative>Numerator: 3947; Denominator: 10568.</narrative>
            </comment>
          </target>
          <actual value="31">
            <comment>
              <narrative>Numerator: 3278; Denominator: 10568.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of adolescent girls and young women reached with HIV prevention programs- defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of adolescent girls and young women reached with HIV prevention programs- defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 168847; Denominator: 370249; Percentage: 45.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="10-14" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="10-14" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="10-14" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="10-14" />
          <comment>
            <narrative>Numerator: 0.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 90957; Denominator: 370249; Percentage: 24.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 90957; Denominator: 370249; Percentage: 24.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 90957; Denominator: 370249; Percentage: 24.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 90957; Denominator: 370249; Percentage: 24.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 90957; Denominator: 370249; Percentage: 24.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 90957; Denominator: 370249; Percentage: 24.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 77890; Denominator: 370249; Percentage: 21.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 77890; Denominator: 370249; Percentage: 21.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 77890; Denominator: 370249; Percentage: 21.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 77890; Denominator: 370249; Percentage: 21.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 77890; Denominator: 370249; Percentage: 21.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 77890; Denominator: 370249; Percentage: 21.04%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 152457; Denominator: 609828.22; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 95546; Denominator: 609828; Percentage: 15.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 51171.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 44375.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 304914; Denominator: 609828.2; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 284621; Denominator: 609828; Percentage: 46.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 152457; Denominator: 609828.22; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 189075; Denominator: 609828; Percentage: 31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="10-14" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 109928.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 79147.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 156421; Denominator: 625683.96; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 173756; Denominator: 625684; Percentage: 27.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 103035.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 70721.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 312842; Denominator: 625684; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 289015; Denominator: 625684; Percentage: 46.2%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 156421; Denominator: 625683.96; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 115259; Denominator: 625684; Percentage: 18.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 66246; Denominator: 625684; Percentage: 10.59%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 49013; Denominator: 625684; Percentage: 7.83%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 160488; Denominator: 641951.71; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 86782; Denominator: 641952; Percentage: 13.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 49291.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 37491.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 320976; Denominator: 641951.7; Percentage: 50%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 202566; Denominator: 641952; Percentage: 31.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 160488; Denominator: 641951.71; Percentage: 25%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 115784; Denominator: 641952; Percentage: 18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 63322.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 52462.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 4153; Denominator: 5862; Percentage: 70.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 2349.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 2349.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 2349.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 2349.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 2349.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 2349.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 1804.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 1804.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 1804.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 1804.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 1804.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 1804.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4308; Denominator: 9574; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1337; Denominator: 9574; Percentage: 14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 820.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 517.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8617; Denominator: 9574; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3603; Denominator: 9574; Percentage: 37.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4309; Denominator: 9574; Percentage: 45.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2266; Denominator: 9574; Percentage: 23.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1384.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 882.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4420; Denominator: 9823; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2529; Denominator: 9823; Percentage: 25.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1434.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 1095.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 8841; Denominator: 9823; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4381; Denominator: 9823; Percentage: 44.6%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4421; Denominator: 9823; Percentage: 45.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1852; Denominator: 9823; Percentage: 18.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1084; Denominator: 9823; Percentage: 11.04%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 768; Denominator: 9823; Percentage: 7.82%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 4535; Denominator: 10079; Percentage: 44.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1168; Denominator: 10079; Percentage: 11.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 650.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 518.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 9071; Denominator: 10079; Percentage: 90%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2283; Denominator: 10079; Percentage: 22.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4536; Denominator: 10079; Percentage: 45%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1115; Denominator: 10079; Percentage: 11.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 674.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 441.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 8521; Denominator: 9491; Percentage: 89.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 4980.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 4980.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 4980.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 4980.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 4980.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 4980.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 3541.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 3541.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 3541.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 3541.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 3541.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;25" />
          <comment>
            <narrative>Numerator: 3541.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 6235; Denominator: 13126; Percentage: 47.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3093; Denominator: 13126; Percentage: 23.6%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1935.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 1158.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12470; Denominator: 13126; Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10645; Denominator: 13126; Percentage: 81.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6235; Denominator: 13126; Percentage: 47.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 7552; Denominator: 13126; Percentage: 57.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 4720.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 2832.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 12794; Denominator: 13467; Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 13130; Denominator: 13467; Percentage: 97.5%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 6397; Denominator: 13467; Percentage: 47.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 8210; Denominator: 13467; Percentage: 61%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 4872.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 3338.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6397; Denominator: 13467; Percentage: 47.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4920; Denominator: 13467; Percentage: 36.5%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2857; Denominator: 13467; Percentage: 21.21%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 2063; Denominator: 13467; Percentage: 15.32%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 13126; Denominator: 13817; Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6043; Denominator: 13817; Percentage: 43.7%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 6563; Denominator: 13817; Percentage: 47.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3233; Denominator: 13817; Percentage: 23.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 2011.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 1222.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 6563; Denominator: 13817; Percentage: 47.5%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 2810; Denominator: 13817; Percentage: 20.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1640.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;25" />
            <comment>
              <narrative>Numerator: 1170.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>RHRB-Other 1 Percentage of PLHIV, people with TB and key populations receiving legal and/or judicial assistance</narrative>
      </title>
      <description>
        <narrative>Module: Reducing human rights-related barriers to HIV/TB services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>RHRB-Other 1 Percentage of PLHIV, people with TB and key populations receiving legal and/or judicial assistance</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="23.6">
          <comment>
            <narrative>Numerator: 38; Denominator: 161.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="23.7">
            <comment>
              <narrative>Numerator: 112; Denominator: 473.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 636; Denominator: 636.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="23.73">
            <comment>
              <narrative>Numerator: 56; Denominator: 236.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 219; Denominator: 219.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="23.63">
            <comment>
              <narrative>Numerator: 56; Denominator: 237.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 417; Denominator: 417.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="23.46">
            <comment>
              <narrative>Numerator: 57; Denominator: 243.</narrative>
            </comment>
          </target>
          <actual value="100">
            <comment>
              <narrative>Numerator: 448; Denominator: 448.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="23.5">
            <comment>
              <narrative>Numerator: 114; Denominator: 485.</narrative>
            </comment>
          </target>
          <actual value="54.5">
            <comment>
              <narrative>Numerator: 477; Denominator: 876.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="23.55">
            <comment>
              <narrative>Numerator: 57; Denominator: 242.</narrative>
            </comment>
          </target>
          <actual value="6.8">
            <comment>
              <narrative>Numerator: 29; Denominator: 428.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="23.3">
            <comment>
              <narrative>Numerator: 116; Denominator: 497.</narrative>
            </comment>
          </target>
          <actual value="5.5">
            <comment>
              <narrative>Numerator: 42; Denominator: 761.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="23.39">
            <comment>
              <narrative>Numerator: 58; Denominator: 248.</narrative>
            </comment>
          </target>
          <actual value="6.3">
            <comment>
              <narrative>Numerator: 23; Denominator: 364.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="23.29">
            <comment>
              <narrative>Numerator: 58; Denominator: 249.</narrative>
            </comment>
          </target>
          <actual value="4.8">
            <comment>
              <narrative>Numerator: 19; Denominator: 397.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases (all forms) notified among prisoners</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="166" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="150" />
          <actual value="228" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="75" />
          <actual value="116" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="75" />
          <actual value="112" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="70" />
          <actual value="127" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="140" />
          <actual value="355" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="70" />
          <actual value="228" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="130" />
          <actual value="319" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="65" />
          <actual value="142" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="65" />
          <actual value="177" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified TB cases (all forms) contributed by non-national TB program providers - community referrals</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="6193" />
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="3902" />
          <actual value="3272" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="7804" />
          <actual value="6593" />
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="3902" />
          <actual value="3321" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="8836" />
          <actual value="7858" />
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="4418" />
          <actual value="3970" />
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="4418" />
          <actual value="3888" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="5022" />
          <actual value="4281" />
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="10044" />
          <actual value="8635" />
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="5022" />
          <actual value="4354" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31" value="86.33">
          <comment>
            <narrative>Numerator: 15624; Denominator: 18097.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 18464; Denominator: 20515.6.</narrative>
            </comment>
          </target>
          <actual value="85.5">
            <comment>
              <narrative>Numerator: 14620; Denominator: 17102.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9231.98; Denominator: 10257.75.</narrative>
            </comment>
          </target>
          <actual value="87.6">
            <comment>
              <narrative>Numerator: 7799; Denominator: 8898.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-07-01" />
          <period-end iso-date="2021-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9231.98; Denominator: 10257.75.</narrative>
            </comment>
          </target>
          <actual value="83.1">
            <comment>
              <narrative>Numerator: 6821; Denominator: 8204.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 19155.7; Denominator: 21284.6.</narrative>
            </comment>
          </target>
          <actual value="85.4">
            <comment>
              <narrative>Numerator: 15656; Denominator: 18337.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-01-01" />
          <period-end iso-date="2022-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9578.25; Denominator: 10643.</narrative>
            </comment>
          </target>
          <actual value="84.3">
            <comment>
              <narrative>Numerator: 7575; Denominator: 8985.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-07-01" />
          <period-end iso-date="2022-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9577.44; Denominator: 10641.6.</narrative>
            </comment>
          </target>
          <actual value="86.4">
            <comment>
              <narrative>Numerator: 8081; Denominator: 9352.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9939.92; Denominator: 11044.35.</narrative>
            </comment>
          </target>
          <actual value="86.7">
            <comment>
              <narrative>Numerator: 8506; Denominator: 9807.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-01-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 19879.8; Denominator: 22088.8.</narrative>
            </comment>
          </target>
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 16975; Denominator: 19497.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2023-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9939.92; Denominator: 11044.35.</narrative>
            </comment>
          </target>
          <actual value="87.4">
            <comment>
              <narrative>Numerator: 8469; Denominator: 9690.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-CIV-C-ACI-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>HIV &amp; TB community responses and reducing stigma and other barriers to accessing treatment and care - Côte d'Ivoire (01-Jan-2024-31-Dec-2026)</narrative>
    </title>
    <description type="1">
      <narrative>Côte d'Ivoire, TB/HIV, Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Réduire l'incidence de la tuberculose de 159 cas pour 100 000 habitants en 2015 à 93 cas pour 100 000 habitants en 2026 / Reduce the incidence of tuberculosis from 159 cases per 100,000 population in 2015 to 93 cases per 100,000 population in 2026; Réduire le taux de mortalité de 36 cas pour 100 000 habitants en 2015 à 11 cas pour 100 000 habitants en 2026 / Reduce the mortality rate from 36 cases per 100,000 population in 2015 to 11 cases per 100,000 population in 2026; Atteindre les 95-95-95 d'ici 2026/Reach the 95-95-95 by 2026. Objectives: Accroître la notification des nouveaux cas et rechutes de tuberculose toutes formes de 20 729 en 2021 à 24 656 en 2026 / Increase notification of new and relapsed cases of all forms of TB from 20,729 in 2021 to 24,656 in 2026; Atteindre 90% de taux de succès thérapeutique chez les nouveaux cas et rechutes de tuberculose toutes formes d’ici 2026 / Achieve an 90% treatment success rate for new and relapsed cases of all forms of TB by 2026; Atteindre 81% de taux de succès thérapeutique chez les malades multi-résistants mis sous traitement de 2ème ligne d’ici 2026 / Achieve an 81% treatment success rate for multi-drug resistant patients who will start 2nd line therapy by 2026; Réduire les nouvelles infections par le VIH de 70% d'ici 2026 / Reduce new HIV infections by 70% by 2026; Réduire la mortalité liée au VIH de 50% d'ici 2026 / Reduce HIV-related deaths by 50% by 2026; Contribuer à la réduction de la stigmatisation, la discrimination et le respect des droits humains en  renforcant l'ensemble des interventions de prévention et de prise en charge du VIH et du sida / Contribute to the reduction of stigma, discrimination, and to the respect for human rights by strengthening all HIV/AIDS prevention and care interventions; Renforcer la gouvernance de la réponse au VIH et au sida et aux IST à tous les niveaux pour en assurer l’accélération, l'efficience, la redevabilité et la durabilité / Strengthen the governance of the response to HIV/AIDS and STIs at all levels to ensure acceleration, efficiency, accountability and sustainability.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="24" role="2" crs-channel-code="23000">
      <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
    </participating-org>
    <participating-org type="24" role="4" crs-channel-code="23000">
      <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
    </participating-org>
    <other-identifier ref="CIV-C-ACIP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2024-01-01" />
    <activity-date type="2" iso-date="2024-01-01" />
    <activity-date type="3" iso-date="2026-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>Paula Hacopian</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>paula.hacopian@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="CI" percentage="100">
      <narrative>Côte d'Ivoire</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="47.74">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="42.26">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="10">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="f8950f0e-59db-4839-9e56-5ad9689ca68d" percentage="0.35">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing for AGYW and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="891c6028-9f9a-427f-8e25-55b502d52054" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Community-based testing outside of KP and AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="26ab57aa-470b-4e99-bff9-92e1452cf6cd" percentage="0.26">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Facility-based testing outside of key population (KP) and adolescent girls and young women (AGYW) programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.19">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="0.66">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="2.55">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="86dc2898-1dfb-4559-a4cb-72cd5a2cd403" percentage="1.45">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; HIV prevention communication, information and demand creation for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="0.06">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="e14e7a7d-49ce-4bb6-8454-ae4224e7a32e" percentage="0.16">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="a120a70d-52df-43de-97e1-765d63db4170" percentage="0.7">
        <description>
          <narrative>HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; HIV prevention communication, information and demand creation for prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="7f6dabab-f06a-4957-b710-a1c3f2f37f3a" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for people in prisons and other closed settings -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for prisoners</narrative>
        </description>
      </budget-item>
      <budget-item code="09268318-342f-41af-84e1-0aab4e2fd8f3" percentage="0.04">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Community empowerment for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="d4788f0c-523b-415c-b8ec-03eaa8789e31" percentage="1.58">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; HIV prevention communication, information and demand creation for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="f1547d57-4fe3-48f6-acd2-f3c9e4e016d1" percentage="0.51">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Needle and syringe programs for PWID</narrative>
        </description>
      </budget-item>
      <budget-item code="d016d725-1006-44b1-8b50-da67f4621072" percentage="0.98">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="394d6538-8808-4811-b96b-d6bf71843cb6" percentage="1.56">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; HIV prevention communication, information and demand creation for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="4ad468bf-4376-466e-944a-b25f3e1b00ee" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="3f39233d-f679-42ce-8532-a7949f0d93ef" percentage="1.73">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="55ece96e-d30c-46d2-8db0-27306b249434" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; HIV prevention communication, information and demand creation for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="6853dd18-909c-4836-8981-2e434afc456c" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="ec84ef8b-ad12-46a3-9175-4f68245fa984" percentage="0">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Sexual and reproductive health services, including STIs, hepatitis, post-violence care for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="e6662a80-0f0d-4611-990c-6044696834dc" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Community mobilization and advocacy for human rights</narrative>
        </description>
      </budget-item>
      <budget-item code="9bcc0e33-1356-4897-a1b3-d9171e326a60" percentage="8.14">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Eliminating stigma and discrimination in all settings</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="0.41">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="10e03ea0-16be-40e1-9fba-682edec921d0" percentage="0.67">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring rights-based law enforcement practices</narrative>
        </description>
      </budget-item>
      <budget-item code="b745fdfb-055f-428b-9634-646cf15f5904" percentage="0.33">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="28c1900d-472f-4af5-94d7-2b92f93ab743" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Increasing access to justice (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="ecc245de-32bf-41ff-8eb1-f5fae2eb1557" percentage="0.52">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Legal literacy ("Know Your Rights") (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="e0bd4666-bd16-440a-81d4-ded76d1d1b10" percentage="0.67">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Reducing HIV-related gender discrimination, harmful gender norms and violence against women and girls in all their diversity</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="16.31">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.06">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="1.91">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="2.13">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="35.71">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="db62704e-5b08-4eb1-b5cb-39a697705c19" percentage="2.24">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Capacity building and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="8c042996-0cb7-4540-ad17-483cf18ec784" percentage="2.48">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="12d82614-1fc1-4696-b954-b899115b31d9" percentage="0.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-led research and advocacy</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.26">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="0.33">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="cb85db5b-1f59-4c7a-ba74-2cb30ee6a84b" percentage="0.1">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Operational Research</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="4.37">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="fd4720c3-77e8-4b8a-8c90-69c1ae68c5e7" percentage="0.22">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Collaboration with other programs/sectors</narrative>
        </description>
      </budget-item>
      <budget-item code="95211519-fdf1-4ae4-964d-27e8afa798cf" percentage="3.23">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Community-based TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="03989069-d574-46fc-9fad-200e03cde744" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Others</narrative>
        </description>
      </budget-item>
      <budget-item code="99e62de4-459a-4fc3-a5da-f5297d23736d" percentage="0.51">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - People in prisons/jails/detention centers</narrative>
        </description>
      </budget-item>
      <budget-item code="8d2f8312-6339-4e40-9c64-84e09bb628b3" percentage="0.04">
        <description>
          <narrative>Tuberculosis -&gt; Key and vulnerable populations (KVP) - TB/DR-TB -&gt; KVP - Urban poor/slum dwellers</narrative>
        </description>
      </budget-item>
      <budget-item code="0b70cc74-9bed-4827-909b-8bc795d35561" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Addressing needs of people in prisons and other closed settings</narrative>
        </description>
      </budget-item>
      <budget-item code="0ed16776-d36f-4d43-a8fc-294a23927ba7" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Community mobilization and advocacy, including support to TB survivor-led groups</narrative>
        </description>
      </budget-item>
      <budget-item code="23608000-3108-4c67-92d0-b1a31eb68b3f" percentage="0.35">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Eliminating TB-related stigma and discrimination</narrative>
        </description>
      </budget-item>
      <budget-item code="96853606-c692-49fd-8be3-aff4fe795705" percentage="0.06">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Legal literacy ("Know Your Rights") (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="4.83">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="602586f6-9a77-484c-bf39-acc8a3151170" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.16">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="c03db068-1593-4995-bf69-fe67549bd239" percentage="0.24">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Treatment and care</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">9766224.70</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">10475642.29</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">9579455.47</value>
    </budget>
    <capital-spend percentage="1.38" />
    <transaction ref="c8b45caa-a31b-4b19-8fc0-684006cb184a">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-12-20" />
      <value currency="USD" value-date="2023-12-20">15216589.97</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9ee3873e-eacd-4ba2-8141-0617d1b62314">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-01-04" />
      <value currency="USD" value-date="2024-01-04">2358501.74</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8f2c222f-4250-4230-ac17-301a12cd19ec">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-16" />
      <value currency="USD" value-date="2024-04-16">2094913.07</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="eb91992e-7f33-40f5-9346-f1e2174c3dc2">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-11" />
      <value currency="USD" value-date="2024-06-11">11286.73</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="328e6da2-2bb4-4cf1-a533-4d88f0f3ce6c">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-02" />
      <value currency="USD" value-date="2024-07-02">2414006.95</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9bc3730f-f544-43de-86ab-f5128fa33eeb">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-07-23" />
      <value currency="USD" value-date="2024-07-23">11278.13</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="72802edc-169c-4818-bc3b-b31a9176efa3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-08-03" />
      <value currency="USD" value-date="2024-08-03">223169.32</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b6fc7a8c-7cad-4e19-8e5c-4aeb3a045bad">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-10-15" />
      <value currency="USD" value-date="2024-10-15">3076599.21</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="32c68436-c1a6-4142-ab65-ae67dc0fb8c0">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-19" />
      <value currency="USD" value-date="2024-12-19">895545.45</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="516b3020-92bf-4a9e-beef-626a1c8c0c5c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-07" />
      <value currency="USD" value-date="2025-01-07">60528.84</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="b44f6839-48c2-4975-9686-7566dd7766f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-14" />
      <value currency="USD" value-date="2025-01-14">35199.83</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="e544193c-ee0f-4827-9a3c-7cac17084533">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-01-14" />
      <value currency="USD" value-date="2025-01-14">65962.44</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="d63fbe88-a9a8-475a-a33f-4bf8f8f4c017">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-02-27" />
      <value currency="USD" value-date="2025-02-27">2020633.60</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="17b05b8b-0215-40e3-bef9-7511b759b439">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-03-20" />
      <value currency="USD" value-date="2025-03-20">35046.32</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="da52ce81-151e-478a-96d8-2bbf3c609d4c">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-05-27" />
      <value currency="USD" value-date="2025-05-27">2333825.09</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="89b6abbe-9224-40a3-a227-ab01e98c9b5a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-06-27" />
      <value currency="USD" value-date="2025-06-27">141857.92</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="444affbd-6099-4536-80e4-1fcb15f1d162">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-06-30" />
      <value currency="USD" value-date="2025-06-30">141857.92</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1e4e2431-d9a2-4de2-9f29-1e12d6c5ffd2">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-12" />
      <value currency="USD" value-date="2025-07-12">27222.56</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="37d84efd-934a-4e58-88c4-f8112460037a">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-07-12" />
      <value currency="USD" value-date="2025-07-12">-26431.88</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="346cc330-a5c3-4a56-8460-46e5d3b99813">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-07-29" />
      <value currency="USD" value-date="2025-07-29">19234.45</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="380a2291-54b5-488f-9fd2-ccf02305b044">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-06" />
      <value currency="USD" value-date="2025-08-06">3243409.15</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f2abdb44-286b-4823-9dd9-f7110cd4017a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-22" />
      <value currency="USD" value-date="2025-08-22">2179553.64</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4d6bc5f5-5a40-4a78-a99b-8477e06a5dec">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-08-22" />
      <value currency="USD" value-date="2025-08-22">21196.21</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="045f98e2-c583-4513-a19b-7802d6f77e37">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-27" />
      <value currency="USD" value-date="2025-08-27">-7988.12</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="95905592-b2ac-4a6c-bd40-ce1bfcd54bd4">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-27" />
      <value currency="USD" value-date="2025-08-27">3.99</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a1113d3e-8460-4b25-8666-e52d05522239">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">1024545.45</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5aacef1a-6b5c-4b2f-90a3-c58a6d5388a7">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">1133734.31</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9133505c-3778-4417-a26a-b5e8dd07c9e0">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-04" />
      <value currency="USD" value-date="2025-11-04">-18113.84</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2af3f0c1-a471-4f72-bdae-0e1861f1ed15">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-06" />
      <value currency="USD" value-date="2025-11-06">-3.99</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9b22ec53-1c79-4659-a1f2-a3d1a5c04f9a">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-11-11" />
      <value currency="USD" value-date="2025-11-11">1133734.31</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f1df440a-eab9-4b0e-8555-9a08db5ad285">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-11-13" />
      <value currency="USD" value-date="2025-11-13">34844.80</value>
      <description>
        <narrative>Funds returned to the Global Fund from CIV-C-ACIP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="78d9bad3-c284-47f4-8b81-6235bbe9c3f6">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-11-21" />
      <value currency="USD" value-date="2025-11-21">-34844.80</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="07c31c03-0d83-4533-bbb7-2400194579ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-01-17" />
      <value currency="USD" value-date="2026-01-17">5478193.74</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d5ee08e1-882d-47ac-9366-583d3b1ecb81">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-01-27" />
      <value currency="USD" value-date="2026-01-27">2948890.21</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="98a2125b-fbbe-4242-b947-a9b44019bf93">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-08" />
      <value currency="USD" value-date="2026-04-08">2516354.33</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0584863c-e797-4298-9f73-3fbb45e18891">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-26" />
      <value currency="USD" value-date="2026-06-26">4114210.93</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b4e83d87-1da8-4c91-a807-51a8737777ea">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-06-26" />
      <value currency="USD" value-date="2026-06-26">-12949.20</value>
      <description>
        <narrative>Global Fund commitment to CIV-C-ACIP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8f0b792b-a1b5-45be-a1c3-7ad7008e21a0">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">1968742.35</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="87b120d1-9d6d-46e8-aa77-c9b22f9d0e31">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-14" />
      <value currency="USD" value-date="2026-07-14">21497.02</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dae1bd43-4133-4ad7-af23-8683be29016d">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-10-20" />
      <value currency="USD" value-date="2026-10-20">2123971.55</value>
      <description>
        <narrative>Global Fund disbursement to CIV-C-ACIP02 (Other Local Organizations).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="CIV-C-ACIP02-EXP-20241231">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">9720760.78</value>
      <description>
        <narrative>Expenditure reported by Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire for CIV-C-ACIP02, Jan 2024 to Dec 2024.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </provider-org>
    </transaction>
    <transaction ref="CIV-C-ACIP02-EXP-20251231">
      <transaction-type code="4" />
      <transaction-date iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-12-31">10069301.59</value>
      <description>
        <narrative>Expenditure reported by Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire for CIV-C-ACIP02, Jan 2025 to Dec 2025.</narrative>
      </description>
      <provider-org type="24">
        <narrative>Alliance Nationale pour la Santé et le Développement en Côte D'Ivoire</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/CIV-C-ACI" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/CIV/2023/TB_HIV/en/CIV-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - TB/HIV - Côte d'Ivoire - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1541-CIV-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/CIV/2023/TB_HIV/fr/CIV-C_FundingRequest_1_fr.zip" format="application/zip">
      <title>
        <narrative>2023 - Funding Request - Window 1 - TB/HIV - Côte d'Ivoire - Français</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1541-CIV-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="fr" />
      <document-date iso-date="2023-03-30" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of EUR 18,420,718 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction with the Host Country’s compliance with the requirements listed at paragraphs (1)(a) and (1)(b) below (“Co-Financing Requirements”). The Grantee acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Host Country fails to: (a) progressively increase government expenditure on health to meet national universal health coverage goals; and/or (b) increase domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee acknowledges and agrees that the Host Country shall, as set out in the co-financing commitment letter to be signed by the Government of Cote d'Ivoire and submitted in form and substance satisfactory to the Global Fund, by 30 June 2024: (a) fulfil a total minimum co-financing commitment; (b) fulfil the programmatic commitments (if any) as stipulated in the co-financing commitment letter; and (c) provide to the Global Fund, by no later than the agreed date of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to: i. the approved annual budget for HIV, TB and RSSH for the upcoming year; and ii. the total expenditure for HIV, TB and RSSH in the previous fiscal year.</narrative>
      </condition>
      <condition type="2">
        <narrative>4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
      <condition type="3">
        <narrative>5 - (1) Grant Funds may be used to pay for the services of an external auditor or for a Supreme Audit Institution approved by the Global Fund retained by the Global Fund for the annual independent audit of the Program (the “External Auditor”) and the Global Fund may disburse such Grant Funds directly to the External Auditor; (2) the Principal Recipient shall consent, no later than 31 mars 2023 to the carrying out of audits of the Program by the External Auditor for the period covering fiscal years 2024, 2025 and 2026 (and other such additional periods as the Global Fund may communicate to the Principal Recipient in writing), and to the terms of reference of the External Auditor and agrees that such terms of reference may be amended from time to time; and (3) without limiting Section 7.5 of the Global Fund Grant Regulations (as amended from time to time), the Principal Recipient shall cooperate fully with the External Auditor to allow the External Auditor to perform its services, including by providing all information and documents requested by the External Auditor or the Global Fund.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="30848" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="38558" />
          <actual value="29894" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="19279" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="19279" />
          <actual value="19316" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="42426" />
          <actual value="37432" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="21213" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="21213" />
          <actual value="21804" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="23237" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="23237" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Differentiated HIV Testing Services.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable people that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="25.88">
          <comment>
            <narrative>Numerator: 61814; Denominator: 238845.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="30">
            <comment>
              <narrative>Numerator: 97041; Denominator: 323470.</narrative>
            </comment>
          </target>
          <actual value="29.18">
            <comment>
              <narrative>Numerator: 94400; Denominator: 323470.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="7.5">
            <comment>
              <narrative>Numerator: 24260.25; Denominator: 323470.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="30">
            <comment>
              <narrative>Numerator: 97041; Denominator: 323470.</narrative>
            </comment>
          </target>
          <actual value="29.18">
            <comment>
              <narrative>Numerator: 94400; Denominator: 323470.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="16.5">
            <comment>
              <narrative>Numerator: 54920; Denominator: 332850.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="33">
            <comment>
              <narrative>Numerator: 109841; Denominator: 332850.</narrative>
            </comment>
          </target>
          <actual value="25.38">
            <comment>
              <narrative>Numerator: 84473; Denominator: 332850.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="33">
            <comment>
              <narrative>Numerator: 109841; Denominator: 332850.</narrative>
            </comment>
          </target>
          <actual value="25.38">
            <comment>
              <narrative>Numerator: 84473; Denominator: 332850.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="18">
            <comment>
              <narrative>Numerator: 61650; Denominator: 342503.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="36">
            <comment>
              <narrative>Numerator: 123301; Denominator: 342503.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: Key and vulnerable populations (KVP) - TB/DR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people with TB (all forms) notified among prisoners; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="355" />
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="165" />
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="331" />
          <actual value="352" />
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="166" />
          <actual value="233" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="153" />
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="307" />
          <actual value="353" />
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="154" />
          <actual value="197" />
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="141" />
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="142" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for men who have sex with men (MSM) and their sexual partners.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 4381; Denominator: 9823; Percentage: 44.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 522; Denominator: 1179; Percentage: 44.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="15-19" />
          <comment>
            <narrative>Numerator: 522; Denominator: 1179; Percentage: 44.27%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 1341; Denominator: 3045; Percentage: 44.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="20-24" />
          <comment>
            <narrative>Numerator: 1341; Denominator: 3045; Percentage: 44.04%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 2518; Denominator: 5599; Percentage: 44.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2022" iso-date="2022-12-31">
          <dimension name="Age" value="25+" />
          <comment>
            <narrative>Numerator: 2518; Denominator: 5599; Percentage: 44.97%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3455; Denominator: 4606; Percentage: 75%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 185; Denominator: 4606; Percentage: 4.02%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 864; Denominator: 4606; Percentage: 18.76%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 3455; Denominator: 4606; Percentage: 75.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 185; Denominator: 4606; Percentage: 4.02%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4002; Denominator: 4708; Percentage: 85%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3146; Denominator: 4708; Percentage: 66.82%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2001; Denominator: 4708; Percentage: 42.5%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4002; Denominator: 4708; Percentage: 85%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3146; Denominator: 4708; Percentage: 66.82%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15-19" />
            <comment>
              <narrative>Numerator: 400.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="20-24" />
            <comment>
              <narrative>Numerator: 920.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="25+" />
            <comment>
              <narrative>Numerator: 1826.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target>
            <comment>
              <narrative>Numerator: 2285; Denominator: 4809; Percentage: 47.52%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 4570; Denominator: 4809; Percentage: 95.03%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>KP-1d Other 1: Percentage of people who use drugs, including injecting drugs, who have benefited from HIV prevention programmes - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for people who use drugs (PUD) and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>KP-1d Other 1: Percentage of people who use drugs, including injecting drugs, who have benefited from HIV prevention programmes - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="85.01">
          <comment>
            <narrative>Numerator: 8756; Denominator: 10300.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="21.25">
            <comment>
              <narrative>Numerator: 1646; Denominator: 7747.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 6584; Denominator: 7747.</narrative>
            </comment>
          </target>
          <actual value="19.79">
            <comment>
              <narrative>Numerator: 1533; Denominator: 7747.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="84.99">
            <comment>
              <narrative>Numerator: 6584; Denominator: 7747.</narrative>
            </comment>
          </target>
          <actual value="19.79">
            <comment>
              <narrative>Numerator: 1533; Denominator: 7747.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="45">
            <comment>
              <narrative>Numerator: 3563; Denominator: 7917.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 7126; Denominator: 7917.</narrative>
            </comment>
          </target>
          <actual value="80.83">
            <comment>
              <narrative>Numerator: 6399; Denominator: 7917.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="90.01">
            <comment>
              <narrative>Numerator: 7126; Denominator: 7917.</narrative>
            </comment>
          </target>
          <actual value="80.83">
            <comment>
              <narrative>Numerator: 6399; Denominator: 7917.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="47.5">
            <comment>
              <narrative>Numerator: 3841; Denominator: 8087.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="94.98">
            <comment>
              <narrative>Numerator: 7681; Denominator: 8087.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for sex workers, their clients and other sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of sex workers reached with HIV prevention programs</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="97.5">
          <comment>
            <narrative>Numerator: 13130; Denominator: 13467.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 10891; Denominator: 11464.</narrative>
            </comment>
          </target>
          <actual value="7.05">
            <comment>
              <narrative>Numerator: 808; Denominator: 11464.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="23.75">
            <comment>
              <narrative>Numerator: 2723; Denominator: 11464.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 10891; Denominator: 11464.</narrative>
            </comment>
          </target>
          <actual value="7.05">
            <comment>
              <narrative>Numerator: 808; Denominator: 11464.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="47.5">
            <comment>
              <narrative>Numerator: 5565; Denominator: 11717.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 11130; Denominator: 11717.</narrative>
            </comment>
          </target>
          <actual value="103.7">
            <comment>
              <narrative>Numerator: 12151; Denominator: 11717.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="94.99">
            <comment>
              <narrative>Numerator: 11130; Denominator: 11717.</narrative>
            </comment>
          </target>
          <actual value="103.7">
            <comment>
              <narrative>Numerator: 12151; Denominator: 11717.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="47.5">
            <comment>
              <narrative>Numerator: 5685; Denominator: 11969.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 11370; Denominator: 11969.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention package for transgender people and their sexual partners.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="34.04">
          <comment>
            <narrative>Numerator: 418; Denominator: 1228.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="65">
            <comment>
              <narrative>Numerator: 141; Denominator: 217.</narrative>
            </comment>
          </target>
          <actual value="4.61">
            <comment>
              <narrative>Numerator: 10; Denominator: 217.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="16.13">
            <comment>
              <narrative>Numerator: 35; Denominator: 217.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="64.98">
            <comment>
              <narrative>Numerator: 141; Denominator: 217.</narrative>
            </comment>
          </target>
          <actual value="4.61">
            <comment>
              <narrative>Numerator: 10; Denominator: 217.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="39.73">
            <comment>
              <narrative>Numerator: 89; Denominator: 224.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="79.9">
            <comment>
              <narrative>Numerator: 179; Denominator: 224.</narrative>
            </comment>
          </target>
          <actual value="57.14">
            <comment>
              <narrative>Numerator: 128; Denominator: 224.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="79.91">
            <comment>
              <narrative>Numerator: 179; Denominator: 224.</narrative>
            </comment>
          </target>
          <actual value="57.14">
            <comment>
              <narrative>Numerator: 128; Denominator: 224.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="47.39">
            <comment>
              <narrative>Numerator: 109; Denominator: 230.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="95.22">
            <comment>
              <narrative>Numerator: 219; Denominator: 230.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of health service delivery sites with a community-led monitoring mechanism in place</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Community systems strengthening.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of health service delivery sites with a community-led monitoring mechanism in place</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="18.67">
          <comment>
            <narrative>Numerator: 56; Denominator: 300.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="80.67">
            <comment>
              <narrative>Numerator: 242; Denominator: 300.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="89.7">
            <comment>
              <narrative>Numerator: 269; Denominator: 300.</narrative>
            </comment>
          </target>
          <actual value="57.67">
            <comment>
              <narrative>Numerator: 173; Denominator: 300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="89.67">
            <comment>
              <narrative>Numerator: 269; Denominator: 300.</narrative>
            </comment>
          </target>
          <actual value="57.67">
            <comment>
              <narrative>Numerator: 173; Denominator: 300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="89.67">
            <comment>
              <narrative>Numerator: 269; Denominator: 300.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="89.7">
            <comment>
              <narrative>Numerator: 269; Denominator: 300.</narrative>
            </comment>
          </target>
          <actual value="64.67">
            <comment>
              <narrative>Numerator: 194; Denominator: 300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="89.67">
            <comment>
              <narrative>Numerator: 269; Denominator: 300.</narrative>
            </comment>
          </target>
          <actual value="64.67">
            <comment>
              <narrative>Numerator: 194; Denominator: 300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 300; Denominator: 300.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 300; Denominator: 300.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of notified patients with all forms of TB (i.e., bacteriologically confirmed + clinically diagnosed) contributed by non-national TB program providers- community referrals; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="36.18">
          <comment>
            <narrative>Numerator: 7884; Denominator: 21793.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="37">
            <comment>
              <narrative>Numerator: 4308; Denominator: 11643.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="37">
            <comment>
              <narrative>Numerator: 8616; Denominator: 23286.</narrative>
            </comment>
          </target>
          <actual value="41.63">
            <comment>
              <narrative>Numerator: 8909; Denominator: 21401.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="37">
            <comment>
              <narrative>Numerator: 4308; Denominator: 11643.</narrative>
            </comment>
          </target>
          <actual value="45.65">
            <comment>
              <narrative>Numerator: 4943; Denominator: 10829.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="38">
            <comment>
              <narrative>Numerator: 9105; Denominator: 23961.</narrative>
            </comment>
          </target>
          <actual value="42.57">
            <comment>
              <narrative>Numerator: 8639; Denominator: 20292.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="38">
            <comment>
              <narrative>Numerator: 4552; Denominator: 11980.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="38">
            <comment>
              <narrative>Numerator: 4553; Denominator: 11981.</narrative>
            </comment>
          </target>
          <actual value="43.21">
            <comment>
              <narrative>Numerator: 4532; Denominator: 10488.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="39">
            <comment>
              <narrative>Numerator: 4808; Denominator: 12328.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="39">
            <comment>
              <narrative>Numerator: 4808; Denominator: 12328.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>TBDT-2-Other 1: Treatment success rate - all forms: percentage of patients with all forms of tuberculosis, bacteriologically confirmed and clinically diagnosed, successfully treated (cured and treatment completed) among all tuberculosis patients who started treatment during a given period, *includes only new patients and relapses followed up by community health workers.</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>TBDT-2-Other 1: Treatment success rate - all forms: percentage of patients with all forms of tuberculosis, bacteriologically confirmed and clinically diagnosed, successfully treated (cured and treatment completed) among all tuberculosis patients who started treatment during a given period, *includes only new patients and relapses followed up by community health workers.</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="85.78">
          <comment>
            <narrative>Numerator: 15824; Denominator: 18447.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 10198; Denominator: 11589.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 20396; Denominator: 23178.</narrative>
            </comment>
          </target>
          <actual value="88">
            <comment>
              <narrative>Numerator: 17316; Denominator: 19678.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="88">
            <comment>
              <narrative>Numerator: 10198; Denominator: 11589.</narrative>
            </comment>
          </target>
          <actual value="88.07">
            <comment>
              <narrative>Numerator: 8529; Denominator: 9684.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="89">
            <comment>
              <narrative>Numerator: 18652; Denominator: 20958.</narrative>
            </comment>
          </target>
          <actual value="89.26">
            <comment>
              <narrative>Numerator: 18444; Denominator: 20663.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="89">
            <comment>
              <narrative>Numerator: 9326; Denominator: 10479.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="89">
            <comment>
              <narrative>Numerator: 9326; Denominator: 10479.</narrative>
            </comment>
          </target>
          <actual value="89.46">
            <comment>
              <narrative>Numerator: 9420; Denominator: 10530.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9704; Denominator: 10782.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 9704; Denominator: 10782.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Contact investigation coverage: Proportion of contacts of people with bacteriologically confirmed TB evaluated for TB among those eligible</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31" value="83.47">
          <comment>
            <narrative>Numerator: 50632; Denominator: 60660.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 40437.7; Denominator: 47573.6.</narrative>
            </comment>
          </target>
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 47741; Denominator: 54812.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-01-01" />
          <period-end iso-date="2024-06-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 20218.65; Denominator: 23786.65.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-07-01" />
          <period-end iso-date="2024-12-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 20219; Denominator: 23787.</narrative>
            </comment>
          </target>
          <actual value="93.72">
            <comment>
              <narrative>Numerator: 25663; Denominator: 27382.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-06-30" />
          <target value="87">
            <comment>
              <narrative>Numerator: 21294.26; Denominator: 24476.16.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-01-01" />
          <period-end iso-date="2025-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 42588.3; Denominator: 48952.2.</narrative>
            </comment>
          </target>
          <actual value="114.32">
            <comment>
              <narrative>Numerator: 51737; Denominator: 45255.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-07-01" />
          <period-end iso-date="2025-12-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 21294; Denominator: 24476.</narrative>
            </comment>
          </target>
          <actual value="124.01">
            <comment>
              <narrative>Numerator: 28668; Denominator: 23118.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-01-01" />
          <period-end iso-date="2026-06-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 22667.49; Denominator: 25186.1.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-07-01" />
          <period-end iso-date="2026-12-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 22667; Denominator: 25186.1.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>